Research Topic · Peer-Reviewed

Cancer Therapy

Cancer therapy comprises the modalities used to eradicate, control, or palliate malignant disease, including surgery, radiation therapy, chemotherapy, targeted molecular agents, immunotherapy, hormonal therapy, and combination regimens selected according to tumor type, stage, molecular profile, and patient condition…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 37× across the literature 🔖 ISSN 2572-3030 🗓 Reviewed July 2026

Overview

Cancer therapy comprises the modalities used to eradicate, control, or palliate malignant disease, including surgery, radiation therapy, chemotherapy, targeted molecular agents, immunotherapy, hormonal therapy, and combination regimens selected according to tumor type, stage, molecular profile, and patient condition. Its objective is to kill or arrest malignant cells while sparing normal tissue, achieved by inducing apoptosis, blocking proliferative and survival signaling, exploiting tumor-specific vulnerabilities, or mobilizing the immune system against the tumor, with treatment resistance a central obstacle. Research relevant to this area spans immunogenomic and immunoassay-based approaches to immunomonitoring, oncolytic virotherapy, immunotherapy, complementary and alternative treatment approaches, pH-sensitive nanomedicine for gynecological cancers, silver-nanoparticle cytotoxicity in tumor cell lines, E-cadherin-mediated suppression of metastasis, therapeutic resistance in cancer relapse, and the management of multiple neoplasms in elderly patients. The journal publishes peer-reviewed work in Cancer Genetics And Biomarkers addressing conventional, targeted, immunological, and nanotechnology-based therapeutic strategies, together with the molecular determinants of treatment response and resistance, connecting experimental and clinical evidence to the design and refinement of cancer treatment across diverse tumor types and contexts of care.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2018

Oncolytic Viruses: Can be Applicable Tools for Cancer Therapy?

Shayestehpour MohammadCorresponding author
Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, I.R. Iran
Exact topic Current Viruses and Treatment Methodologies doi:10.14302/issn.2691-8862.jvat-18-2209
2020

pH-Sensitive Nanomedicine for Treating Gynaecological Cancers

Vishwanath Prasad PramodCorresponding author
Center for Biomedical Research, Population Council, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA
Exact topic Women's Reproductive Health Cited by 8 doi:10.14302/issn.2381-862X.jwrh-19-3143
2015

Epigenetics and Nutrition

Lundstrom KennethCorresponding author
PanTherapeuitcs, Rue des Remparts 4, CH1095 Lutry, Switzerland
Exact topic International Journal of Nutrition Cited by 2 doi:10.14302/issn.2379-7835.ijn-14-603
2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061

How this research is being cited

The 12 articles above have been cited 37 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Cancer Therapy, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Cancer Genetics And Biomarkers (ISSN 2572-3030).

Journal editorial board
Dr. Charlie Gourley · United Kingdom Dr. Xinyu Chen · United States Dr. Guru Prasad Maiti · United States

This page summarises published research for orientation; it is not medical or professional advice.